BeyondSpring (BYSI) News Today $1.77 +0.05 (+2.91%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$1.76 -0.01 (-0.28%) As of 02/21/2025 07:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period BeyondSpring (NASDAQ:BYSI) Shares Up 0.6% - What's Next?BeyondSpring (NASDAQ:BYSI) Stock Price Up 0.6% - Time to Buy?February 21 at 12:14 AM | marketbeat.comSEED Therapeutics Secures FDA Rare Pediatric and Orphan Drug Designations for ST-01156January 29, 2025 | msn.comBeyondSpring to sell portion of equity interest in SEED for $35.4MEli LillyJanuary 28, 2025 | markets.businessinsider.comBeyondSpring sells SEED Therapeutics shares for $35.4MJanuary 28, 2025 | msn.comSEED Receives FDA Rare Pediatric Disease and Orphan Drug Designations for Lead Oncology Asset RBM39 Degrader and Enters Strategic Transactions with New InvestorsJanuary 28, 2025 | globenewswire.comBeyondSpring Announces $35.4 Million Sale of a Portion of Equity Interest in SEED Therapeutics to Advance Lead Asset Plinabulin to Anti-Cancer Registrational StudiesJanuary 28, 2025 | globenewswire.comBeyondSpring (NASDAQ:BYSI) Shares Down 1.4% - Here's WhyBeyondSpring (NASDAQ:BYSI) Stock Price Down 1.4% - Here's WhyJanuary 25, 2025 | marketbeat.comBeyondSpring (NASDAQ:BYSI) Trading 4.5% Higher - Here's WhyBeyondSpring (NASDAQ:BYSI) Stock Price Up 4.5% - Here's What HappenedNovember 27, 2024 | marketbeat.comBeyondSpring presents efficacy results from Phase 2 IIT study of plinabulinNovember 12, 2024 | markets.businessinsider.comBeyondSpring Presents Updated Efficacy Results from a Phase 2 IIT Study of Triple IO Combo of Pembrolizumab plus Plinabulin/Docetaxel in Metastatic NSCLC after Progressing on Prior Immune Checkpoint Inhibitors at the 39th SITC Annual MeetingNovember 11, 2024 | globenewswire.comBYSI Sees Quick 5.39% Surge Amid Low Trading VolumeOctober 2, 2024 | gurufocus.comBeyondSpring Presents Efficacy/Safety Results from a Phase 2 Study of Pembrolizumab plus Plinabulin/Docetaxel in Metastatic NSCLC after Progressing on First-Line Immune Checkpoint Inhibitors at ESMO Congress 2024September 16, 2024 | globenewswire.comBeyondSpring Presents Final Data Analysis of DUBLIN-3 Phase 3 Study in 2L/3L EGFR Wild-type NSCLC at ESMO Congress 2024September 16, 2024 | globenewswire.comBeyondSpring (NASDAQ:BYSI) Trading Up 3.3%BeyondSpring (NASDAQ:BYSI) Trading 3.3% HigherSeptember 12, 2024 | marketbeat.comBeyondSpring Announces Oral Presentation at the 2024 World Conference on Lung Cancer and Two Poster Presentations During ESMO Congress 2024 Showcasing its Lead Anti-Cancer Asset, PlinabulinSeptember 3, 2024 | globenewswire.comBeyondSpring (NASDAQ:BYSI) Stock Price Down 0.5%BeyondSpring (NASDAQ:BYSI) Shares Down 0.5%August 22, 2024 | marketbeat.comSEED Therapeutics (SEED) Enters into Strategic Research Collaboration with Eisai Co., Ltd. to Discover and Develop Novel Molecular Glue Degraders for Neurodegeneration and Oncology IndicationsAugust 6, 2024 | globenewswire.comBeyondSpring (NASDAQ:BYSI) Trading Up 3.1%BeyondSpring (NASDAQ:BYSI) Stock Price Up 3.1%July 13, 2024 | marketbeat.comBeyondSpring (NASDAQ:BYSI) Shares Down 8.8% BeyondSpring (NASDAQ:BYSI) Trading Down 8.8%June 21, 2024 | marketbeat.com4,958,143 Shares in BeyondSpring Inc. (NASDAQ:BYSI) Bought by Decheng Capital LLCDecheng Capital LLC acquired a new position in shares of BeyondSpring Inc. (NASDAQ:BYSI - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 4,958,143 shares of the company's stock, valued aMay 30, 2024 | marketbeat.comBeyondSpring (NASDAQ:BYSI) shareholders have earned a 141% return over the last yearMay 22, 2024 | finance.yahoo.comBeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED TherapeuticsMay 16, 2024 | globenewswire.comBeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and Updates for SEED TherapeuticsMay 3, 2024 | globenewswire.comBeyondSpring GAAP EPS of -$0.54, revenue of $1.75MApril 30, 2024 | msn.comBeyondSpring Provides Business Update and Reports Year End 2023 Financial ResultsApril 29, 2024 | globenewswire.comBeyondSpring Files 2023 Annual Report on Form 20-FApril 29, 2024 | globenewswire.comBeyondSpring Inc. (NASDAQ:BYSI) Sees Significant Increase in Short InterestBeyondSpring Inc. (NASDAQ:BYSI - Get Free Report) was the target of a large growth in short interest during the month of March. As of March 15th, there was short interest totalling 2,350,000 shares, a growth of 25.0% from the February 29th total of 1,880,000 shares. Based on an average trading volume of 200,900 shares, the days-to-cover ratio is presently 11.7 days. Approximately 9.9% of the shares of the company are short sold.March 30, 2024 | marketbeat.comBeyondSpring Announces First Patient Dosed with Pembrolizumab, Plinabulin Plus Etoposide/Platinum in a Phase 2 Investigator-initiated Study of First-Line Extensive-Stage Small-Cell Lung CancerMarch 25, 2024 | globenewswire.comBYSI Oct 2024 7.500 callMarch 14, 2024 | finance.yahoo.com4,958,143 Shares in BeyondSpring Inc. (NASDAQ:BYSI) Bought by Decheng Capital Management III Cayman LLCDecheng Capital Management III Cayman LLC bought a new position in shares of BeyondSpring Inc. (NASDAQ:BYSI - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 4,958,143 shares of the companyMarch 13, 2024 | marketbeat.comBYSI Mar 2024 7.500 callMarch 7, 2024 | finance.yahoo.comU.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.04%March 6, 2024 | msn.comRetail investors invested in BeyondSpring Inc. (NASDAQ:BYSI) up 125% last week, insiders too were rewardedMarch 6, 2024 | finance.yahoo.comBeyondSpring Regains Compliance with Nasdaq Minimum Bid Price and Periodic Filing RequirementsMarch 5, 2024 | finance.yahoo.comBeyondSpring Inc. (BYSI) stock historical prices & data – Yahoo FinanceFebruary 22, 2024 | uk.finance.yahoo.comBeyondSpring Inc BYSIJanuary 18, 2024 | morningstar.comBeyondSpring Receives Nasdaq Delinquency Notice Regarding Late Filing of Its Form 6-KJanuary 18, 2024 | finance.yahoo.comBeyondSpring gets Nasdaq delinquency noticeJanuary 11, 2024 | msn.comBeyondSpring Stock (NASDAQ:BYSI) Insider TradesDecember 27, 2023 | benzinga.comBeyondSpring Stock (NASDAQ:BYSI) Dividends: History, Yield and DatesDecember 27, 2023 | benzinga.comOncternal slips after early data for lymphoma therapyDecember 26, 2023 | seekingalpha.comPassage Bio stock climbs 9% on dementia study, program updateDecember 20, 2023 | msn.comBeyondSpring regains compliance with Nasdaq minimum bid price ruleOctober 31, 2023 | msn.comBeyondSpring and Professor K. Eisenmann of the University of Toledo College of Medicine Present Poster Highlighting Plinabulin’s Anti-cancer Efficacy in Primary and Recurrent Glioblastoma Patient Derived Invasive Neurosphere ModelsOctober 31, 2023 | finance.yahoo.comBeyondSpring Regains Compliance with Nasdaq Minimum Bid Price RequirementOctober 30, 2023 | finance.yahoo.comSEED Therapeutics Discloses Novel Molecular Glue IND Candidate for Cancer at “Targeted Protein Degradation Think Tank” SymposiumOctober 26, 2023 | markets.businessinsider.comSEED Therapeutics, a BeyondSpring Subsidiary, Appoints Mr. Ko-Yung Tung to the Board of DirectorsOctober 23, 2023 | stockhouse.comBeyondSpring, Inc.: BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price RequirementsOctober 5, 2023 | finanznachrichten.deBeyondSpring and Leading Cancer Center to Present Poster at SITC's 38th Annual MeetingSeptember 27, 2023 | benzinga.comBeyondSpring and Leading Cancer Center to Present Poster at SITC’s 38th Annual MeetingSeptember 27, 2023 | finance.yahoo.com Get BeyondSpring News Delivered to You Automatically Sign up to receive the latest news and ratings for BYSI and its competitors with MarketBeat's FREE daily newsletter. Email Address BYSI Media Mentions By Week BYSI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BYSI News Sentiment▼0.750.60▲Average Medical News Sentiment BYSI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BYSI Articles This Week▼10▲BYSI Articles Average Week Get BeyondSpring News Delivered to You Automatically Sign up to receive the latest news and ratings for BYSI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ACIU News Today HRTX News Today ELDN News Today ITOS News Today DMAC News Today RZLT News Today AVIR News Today TNGX News Today MNPR News Today SOPH News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BYSI) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BeyondSpring Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BeyondSpring With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
